Shree Ganesh Remedies Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Net profit of Shree Ganesh Remedies declined 4.86% to Rs 6.27 crore in the quarter ended March 2026 as against Rs 6.59 crore during the previous quarter ended March 2025. Sales rose 35.90% to Rs 33.20 crore in the quarter ended March 2026 as against Rs 24.43 crore during the previous quarter ended March 2025.

For the full year,net profit declined 23.02% to Rs 17.76 crore in the year ended March 2026 as against Rs 23.07 crore during the previous year ended March 2025. Sales rose 0.64% to Rs 109.29 crore in the year ended March 2026 as against Rs 108.60 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 14 May 2026.

Shree Ganesh Remedies Ltd rose 3.78% today to trade at Rs 535. The BSE Healthcare index is up 0.27% to quote at 43607.96. The index is up 4.13 % over last one month. Among the other constituents of the index, Themis Medicare Ltd increased 2.49% and Dr Reddys Laboratories Ltd added 2.31% on the day. The BSE Healthcare index went up 2.14 % over last one year compared to the 2.79% fall in benchmark SENSEX.

Shree Ganesh Remedies Ltd has added 11.02% over last one month compared to 4.13% gain in BSE Healthcare index and 5.15% rise in the SENSEX. On the BSE, 900 shares were traded in the counter so far compared with average daily volumes of 5550 shares in the past one month. The stock hit a record high of Rs 828 on 23 Apr 2025. The stock hit a 52-week low of Rs 381.1 on 27 Jan 2026.

Shree Ganesh Remedies announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 6 April 2026.

Powered by Capital Market - Live News